Oruka Therapeutics, Inc.
ORKA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $62 | $37 | $42 | $53 |
| Short-Term Investments | $314 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $1 | $0 | $0 | $1 |
| Total Curr. Assets | $377 | $38 | $43 | $54 |
| Property Plant & Equip (Net) | $1 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $18 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $19 | $0 | $0 | $1 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $396 | $38 | $43 | $55 |
| Liabilities | – | – | – | – |
| Payables | $3 | $0 | $0 | $1 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $9 | $1 | $1 | $2 |
| Total Curr. Liab. | $13 | $1 | $1 | $3 |
| LT Debt | $1 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $1 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $1 | $0 | $0 | $0 |
| Total Liabilities | $14 | $1 | $1 | $4 |
| Equity | – | – | – | – |
| Pref Stock | $3 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$84 | -$189 | -$183 | -$173 |
| AOCI | -$0 | $0 | $0 | $0 |
| Other Equity | $463 | $226 | $225 | $225 |
| Total Equity | $382 | $37 | $42 | $51 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $396 | $38 | $43 | $55 |
| Net Debt | -$61 | -$37 | -$42 | -$53 |